FR2226662A1 - - Google Patents

Info

Publication number
FR2226662A1
FR2226662A1 FR7413949A FR7413949A FR2226662A1 FR 2226662 A1 FR2226662 A1 FR 2226662A1 FR 7413949 A FR7413949 A FR 7413949A FR 7413949 A FR7413949 A FR 7413949A FR 2226662 A1 FR2226662 A1 FR 2226662A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7413949A
Other versions
FR2226662B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2226662A1 publication Critical patent/FR2226662A1/fr
Application granted granted Critical
Publication of FR2226662B1 publication Critical patent/FR2226662B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7413949A 1973-04-23 1974-04-22 Expired FR2226662B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35386073A 1973-04-23 1973-04-23

Publications (2)

Publication Number Publication Date
FR2226662A1 true FR2226662A1 (fr) 1974-11-15
FR2226662B1 FR2226662B1 (fr) 1979-09-28

Family

ID=23390897

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7413949A Expired FR2226662B1 (fr) 1973-04-23 1974-04-22

Country Status (5)

Country Link
JP (1) JPS5012227A (fr)
DE (1) DE2419230A1 (fr)
FR (1) FR2226662B1 (fr)
GB (1) GB1442546A (fr)
ZA (1) ZA741802B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4403037A (en) 1980-10-10 1983-09-06 American Hoechst Corporation Erythrocyte preparations and use thereof in hemagglutination tests
EP0131974A1 (fr) * 1983-06-08 1985-01-23 Akzo N.V. Détermination d'antigènes delta dans les fluides corporels
US5079173A (en) * 1987-08-19 1992-01-07 Shionogi & Co., Ltd. Methods, hybridomas, monoclonal antibodies and sensitized cells for measuring hbs antigen

Also Published As

Publication number Publication date
FR2226662B1 (fr) 1979-09-28
AU6697174A (en) 1975-09-25
JPS5012227A (fr) 1975-02-07
ZA741802B (en) 1975-02-26
GB1442546A (en) 1976-07-14
DE2419230A1 (de) 1974-11-14

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
FR2256247B1 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
FR2226662B1 (fr)
AU477823B2 (fr)
AR195311A1 (fr)
AR196382A1 (fr)
AU476873B1 (fr)
AU477824B2 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse